alexa SumiY | OMICS International
ISSN: 2165-7548

Emergency Medicine: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
View More»


Department of Emergency and Critical Care Medicine, Juntendo University, Urayasu Hospital, Chiba, Japan.


He is working in Department of Emergency and Critical Care Medicine, Juntendo University, Urayasu Hospital, Chiba, Japan. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his/her wide range of publications in various national and international journals. He is the Editorial Board Member of Emergency Medicine.
Research Interest
Pseudoaneurysm; Pediatrics; Abdominal injury;Transarterial embolization.

Health-Related Quality of Life in Patients with Asthma, Survey based Study in Karachi, Pakistan

Safila Naveed, Asra Hameed, Neelam Sharif, Fatima Qamar, Syeda Sarah Abbas, Tanweer Alam and Sumiyya Masood

Research Article: J Bioequiv Availab

DOI: 10.4172/jbb.1000290

Influence of Pneumococcal Conjugate Vaccine on Otitis Media

Masaru Kunimoto, Sachio Takeno, Katsuhiro Hirakawa, Hirotoshi Sugino and Takahiro Sumiya

Short Communication: Otolaryngol (Sunnyvale) 2016, 6: 236

DOI: 10.4172/2161-119X.1000236

NK-1 Receptor Antagonists: Who Truly Need them and their Cost-Effectiveness Analysis?

Akihito Kubo, Ikuto Tsukiyama, Sumiyo Tsukiyama, Masayuki Ejiri, Katsuhiko Matsuura, Etsuro Yamaguchi and Masahiko Ando

Commentary: Chemotherapy (Los Angel) 2016, 5: 197

DOI: 10.4172/2167-7700.1000197

A Pilot Study- Neoadjuvant Chemotherapy with Gemcitabine and S1 in Patients with Resectable and Borderline Resectable Pancreatic Cancer

Akira Matsushita, Yoshiharu Nakamura, Hiroki Sumiyoshi, Takayuki Aimoto, Tadashi Yokoyama, and Eiji Uchida

Research Article: J Carcinog Mutagen 2013, S9- 006

DOI: 10.4172/2157-2518.S9-006

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7